Duggan Veterinary Supplies Limited has initiated an urgent recall of its veterinary medicine, Catophos 100 mg/ml + 0.05 mg/ml Solution for Injection, used in horses, cattle, and dogs. The action follows the discovery of visible particles in some vials, prompting a Class I recall — the highest level of product recall indicating a potential risk to animal safety.
Details of the Recalled Product
The affected product, marketed under the authorization number Vm 20916/3000, was distributed across veterinary practices and wholesalers in the UK. The recall specifically covers the following batch:
| Batch Number | Date of Manufacture | Expiry Date |
|---|---|---|
| 23K206 | November 2023 | October 2025 |
According to the Veterinary Medicines Directorate, this recall requires immediate action at the veterinarian level. All recipients are instructed to locate and quarantine the affected stock to prevent further use until further notice from the manufacturer.
Reason for the Recall
The company identified visible particulate matter within some vials of the Catophos injection. While the exact nature of the particles has not been publicly detailed, the presence of such contamination can compromise the sterility and effectiveness of the product, posing potential health risks to animals under treatment. In veterinary use, any contamination could lead to adverse reactions or infections following injection, hence the precautionary recall.
Actions Required from Veterinarians and Wholesalers
Duggan Veterinary Supplies Limited has already begun reaching out to wholesalers and veterinary professionals to review their stock immediately. All potentially affected vials should be identified and isolated to avoid accidental use. It is recommended that veterinary practices double-check their inventory systems for the batch number 23K206 and follow the recall protocol issued by the supplier.
Veterinarians and distributors are urged to report any adverse reactions or suspected issues related to the use of the affected product to the manufacturer or through the usual veterinary reporting channels.
Contact for Further Information
For more details or to confirm recall arrangements, Duggan Veterinary Supplies Limited can be contacted via email at [email protected] or by phone at 02476 100 696. The company has assured that it is working closely with the Veterinary Medicines Directorate to ensure all recalled stock is safely removed from circulation.
About Catophos Injection
Catophos Injection is a veterinary solution commonly used for metabolic support in animals such as horses, cattle, and dogs. It contains 100 mg/ml of organic phosphorus compound and 0.05 mg/ml of cyanocobalamin (Vitamin B12). These components are often prescribed to aid in recovery from fatigue, improve metabolism, and support general vitality in livestock and companion animals.
While no adverse events have been reported so far, the recall underscores the importance of vigilance and prompt action when handling injectable veterinary products. The Veterinary Medicines Directorate advises all practitioners to maintain regular quality checks and immediately report any abnormalities noticed in medicinal vials.
Ensuring Animal Safety
This recall serves as a reminder of the stringent safety standards in place to protect animal health. Veterinary professionals are encouraged to monitor updates from both the manufacturer and the Directorate for any further instructions or follow-up actions regarding the Catophos recall.
For continuous updates on veterinary product safety and recall alerts, stay connected with pessnews.in.